Doctor of Philosophy

dissertationAtrial fibrillation (AF) is the leading cause of ischemic stroke and is the most commonly observed arrhythmia in clinical cardiology. Catheter ablation of AF, in which specific regions of cardiac anatomy associated with AF are intenionally injured to create scar tissue, has been honed over the last 15 years to become a relatively common and safe treatment option. However, the success of these anatomically driven ablation strategies, particularly in hearts that have been exposed to AF for extended periods, remains poor. AF induces changes in the electrical and structural properties of the cardiac tissue that further promotes the permanence of AF. In a process known as electroanatomical (EAM) mapping, clinicians record time signals known as electrograms (EGMs) from the heart and the locations of the recording sites to create geometric representations, or maps, of the electrophysiological properties of the heart. Analysis of the maps and the individual EGM morphologies can indicate regions of abnormal tissue, or substrates that facilitate arrhythmogenesis and AF perpetuation. Despite this progress, limitations in the control of devices currently used for EAM acquisition and reliance on suboptimal metrics of tissue viability appear to be hindering the potential of treatment guided by substrate mapping. In this research, we used computational models of cardiac excitation to evaluate param- eters of EAM that affect the performance of substrate mapping. These models, which have been validated with experimental and clinical studies, have yielded new insights into the limitations of current mapping systems, but more importantly, they guided us to develop new systems and metrics for robust substrate mapping. We report here on the progress in these simulation studies and on novel measurement approaches that have the potential to improve the robustness and precision of EAM in patients with arrhythmias. Appropriate detection of proarrhythmic substrates promises to improve ablation of AF beyond rudimentary destruction of anatomical targets to directed targeting of complicit tissues. Targeted treatment of AF sustaining tissues, based on the substrate mapping approaches described in this dissertation, has the potential to improve upon the efficacy of current AF treatment options

Functional Mapping of Three-Dimensional Electrical Activation in Ventricles

University of Minnesota Ph.D. dissertation. 2010. Major: Biomedical Engineering. Advisor: Bin He. 1 computer file (PDF); 139 pages.Ventricular arrhythmias account for nearly 400,000 deaths per year in the United States alone. Electrical mapping of the ventricular activation could facilitate the diagnosis and treatment of arrhythmias, e.g. guiding catheter ablation. To date, both direct mapping and non-contact mapping techniques have been routinely used in electrophysiology labs for obtaining the electrical activity on the endocardial surface. Non-invasive functional mapping methods are also developed to estimate the electrical activity on the epicardium or on both epicardium and endocardium from the body surface measurements. Though successful, the results using above methods are all limited on the surface of the heart and thus cannot directly characterize the cardiac events originating within the myocardial wall. Our group's goal is to develop a functional mapping method to estimate the three-dimensional cardiac electrical activity from either non-invasive body surface potential maps or minimally-invasive intracavitary potential maps, by solving the so-called "inverse problem". Hence the information under the surface of the heart could be revealed to better characterize the cardiac activation. In the present thesis study, the previously developed three-dimensional cardiac electrical imaging (3DCEI) approach has been further investigated. Its function is expanded for not only estimating the global activation sequence but also reconstructing the potential at any myocardial site throughout the ventricle. New algorithms under the 3DCEI scheme are also explored for more powerful mapping capability. The performance of the enhanced 3DCEI approach is rigorously evaluated in both control and diseased swine models when the clinical settings are mimicked. The promising results validate the feasibility of estimating detailed three-dimensional cardiac activation by using the 3DCEI approach, and suggest that 3DCEI has great potential of guiding the clinical management of cardiac arrhythmias in a more efficient way

Cardiac Activation Mapping using Ultrasound Current Source Density Imaging.

Intracardiac ablation procedures to correct drug-resistant arrhythmias require accurate maps of cardiac activation. Conventional methods are time-consuming and have poor spatial resolution (5- 10 mm). The goal of this dissertation was to develop a new method, Ultrasound Current Source Density Imaging (UCSDI), to map biological currents. UCSDI is based on the acousto-electric (AE) effect, a modulation of the electric resistivity by acoustic pressure. If a current passes through the focal region of an ultrasound transducer, a voltage modulated at the ultrasonic frequency can be measured with a pair of electrodes located distal to the focal zone. By sweeping the focal zone, UCSDI can map a distributed current field. UCSDI has several potential advantages as a technique for mapping cardiac activation currents: high spatial resolution determined by the typically sub-mm focal characteristics of the ultrasound beam, short mapping time using electronically steered ultrasonic beams, and automatic registration with B-mode ultrasound images without sophisticated mathematical algorithms. UCSDI was first validated by mapping an artificially generated 2D current distribution. It was compared to sequential electrode mapping, computer simulation as well as to an inverse algorithm. In this study it was possible to use UCSDI to locate monopolar current sources to within 1-mm of their true locations without making any prior assumptions about the source geometry. UCSDI was then used to detect and map biological currents in an isolated rabbit heart. Both UCSDI and normal low frequency electrocardiograms (ECG) were measured simultaneously by tungsten electrodes embedded in the left ventricle. The motion of the heart was significantly reduced by perfusing it with an excitation contraction de-coupler. Measured UCSDI maps showed temporal and spatial patterns consistent with a spreading activation wave and timing consistent with normal ECG signals. UCSDI was then combined with ultrasonic strain imaging in a new method for electromechanical imaging. This combined method was used to make localized measurements of electromechanical delay. This method could be useful in cardiac resynchronization therapy for placing pacemaker leads.Ph.D.Biomedical EngineeringUniversity of Michigan, Horace H. Rackham School of Graduate Studieshttp://deepblue.lib.umich.edu/bitstream/2027.42/60687/1/rolafsso_1.pd

Arrhythmogenic Right Ventricular Cardiomyopathy: Prognostic Value of Electroanatomic Voltage Mapping

Background: Endocardial voltage mapping (EVM) identifies low-voltage right ventricular (RV) areas, which may represent the electroanatomic scar substrate of life-threatening tachyarrhythmias. We prospectively assessed the prognostic value of EVM in a consecutive series of patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). Methods: We studied 69 consecutive ARVC patients [47 males; median age 35 years(28-45)] who underwent electrophysiological study and both bipolar and unipolar EVM. The extent of confluent bipolar (<1.5mV) and unipolar (<6.0mV) low-voltage electrograms was estimated using the CARTO-incorporated area calculation software. Results: Fifty-three patients (77%) showed ≥1 RV electroanatomic scars with an estimated burden of bipolar vs unipolar low-voltage areas of 24.8% (7.2-31.5) and 64.8% (39.8-95.3), respectively (P=0.009). In the remaining patients with normal bipolar-EVM (n=16;23%), the use of unipolar EVM unmasked ≥1 region of low-voltage electrogram affecting 26.2% (11.6-38.2) of RV wall. During a median follow-up of 41 (28-56) months, 19(27.5%) patients experienced arrhythmic events, such as sudden death (n=1), appropriate ICD interventions (n=7), or sustained ventricular tachycardia (n=11). Univariate predictors of arrhythmic outcome included previous cardiac arrest or syncope (HR=3.4; 95%CI:1.4-8.8; P=0.03) and extent of bipolar low-voltage areas (HR=1.7 per 5%; 95%CI=1.5-2; P<0.001), while the only independent predictor was the bipolar low-voltage electrogram burden (HR=1.6 per 5%; 95% CI:1.2-1.9; P<0.001). Patients with normal bipolar-EVM had an uneventful clinical course. Conclusions: The extent of bipolar RV endocardial low-voltage area was a powerful predictor of arrhythmic outcome in ARVC, independently of history and RV dilatation/dysfunction. A normal bipolar-EVM characterized a low-risk subgroup of ARVC patients

2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias

Ventricular arrhythmias are an important cause of morbidity and mortality and come in a variety of forms, from single premature ventricular complexes to sustained ventricular tachycardia and fibrillation. Rapid developments have taken place over the past decade in our understanding of these arrhythmias and in our ability to diagnose and treat them. The field of catheter ablation has progressed with the development of new methods and tools, and with the publication of large clinical trials. Therefore, global cardiac electrophysiology professional societies undertook to outline recommendations and best practices for these procedures in a document that will update and replace the 2009 EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias. An expert writing group, after reviewing and discussing the literature, including a systematic review and meta-analysis published in conjunction with this document, and drawing on their own experience, drafted and voted on recommendations and summarized current knowledge and practice in the field. Each recommendation is presented in knowledge byte format and is accompanied by supportive text and references. Further sections provide a practical synopsis of the various techniques and of the specific ventricular arrhythmia sites and substrates encountered in the electrophysiology lab. The purpose of this document is to help electrophysiologists around the world to appropriately select patients for catheter ablation, to perform procedures in a safe and efficacious manner, and to provide follow-up and adjunctive care in order to obtain the best possible outcomes for patients with ventricular arrhythmias

Non-Invasive Electrocardiographic Mapping of Arrhythmia and Arrhythmogenic substrate in the Human Ventricle.

PhD Theses.The ablation of ventricular tachycardia often involves mapping when the arrhythmia is ongoing. This is often limited by haemodynamic instability. Non-invasive electrocardiographic mapping (ECGI) may aid in the mapping process by allowing expedient localisation. However, insufficient testing of this technology against ground truth data has been conducted. Furthermore, the system could have utility in detection of arrhythmogenic substrate. Current clinical practice uses echocardiography to risk stratify patients for implantation of intracardiac defibrillators (ICDs). Invasive epicardial electrogram data was collected in 8 patients. Activation and repolarisation times were compared to ECGI derived data showing modest correlation. A detailed analysis of ventricular tachycardia sites of origin in the heart was elucidated using validated electrophysiological techniques. These were compared to ECGI derived data in 18 patients, showing better accuracy than the 12 lead ECG with a resolution of ~2.2cm suggesting it may be a useful adjunctive tool in mapping unstable VT. ECGI derived data collected during sinus rhythm was compared to invasive electrogram maps in 16 patients. The capacity of ECGI to localise scar showed modest accuracy. ECGI and Cardiac MRI scans were performed in 21 patients with cardiac amyloidosis. ECGI showed cardiac amyloidosis to be associated with both ventricular conduction and repolarization abnormalities, supporting the hypothesis that arrhythmic mechanisms may be linked to mortality in this condition